Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368709 | 1.00 | CA2 (0.44) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL649656 | 1.00 | CA2 (0.44) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL4929770 | 0.88 | CA2 (0.42) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL929572 | 0.88 | CA2 (0.42) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL1243925 | 0.88 | CA2 (0.42) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL7154999 | 0.86 | CA2 (0.50) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL18817541 | 0.86 | CA2 (0.50) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL714194 | 0.86 | CA2 (0.41) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL20707235 | 0.86 | CA2 (0.41) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 | |
| SCHEMBL21409717 | 0.84 | CA2 (0.40) | CA2ALDH1A1NPSR1TMEM97SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4640769-A1 | CONDUCTIVE POLYMER-CONTAINING DISPERSION, SOLID ELECTROLYTE CAPACITOR, AND PRODUCTION METHOD FOR SAME | Resonac Corporation (JP) | 2025-10-29 | — | — | EP | claimed |
| US-12312480-B2 | Aqueous ink, ink cartridge and ink jet recording method | CANON KABUSHIKI KAISHA (JP) | 2025-05-27 | — | — | US | claimed |
| WO-2024135579-A1 | CONDUCTIVE POLYMER-CONTAINING DISPERSION, SOLID ELECTROLYTE CAPACITOR, AND PRODUCTION METHOD FOR SAME | 株式会社レゾナック | 2024-06-27 | — | — | WO | claimed |
| CN-111518561-B | Silicon etchant and application thereof | 才将科技股份有限公司 | 2021-09-28 | — | — | CN | claimed |
| US-11084981-B2 | Silicon etchant with high Si/SiO2 etching selectivity and application thereof | CJ TECHNOLOGY CO., LTD. (TW) | 2021-08-10 | — | — | US | claimed |
| CN-111518561-A | Silicon etchant and application thereof | 才将科技股份有限公司 | 2020-08-11 | — | — | CN | claimed |
| US-20200248074-A1 | Silicon etchant with high Si/SiO2 etching selectivity and Application thereof | CJ TECHNOLOGY CO., LTD. (TW) | 2020-08-06 | — | — | US | claimed |
| EP-2619179-A1 | MATRIX METALLOPROTEINASE INHIBITORS | Ranbaxy Laboratories Limited (IN) | 2013-07-31 | — | — | EP | claimed |
| EP-2460842-A2 | Novel energetic polyphosphazenes | The Secretary of State For Defence (GB) | 2012-06-06 | — | — | EP | claimed |
| WO-2012038944-A1 | MATRIX METALLOPROTEINASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2012-03-29 | — | — | WO | claimed |
| WO-2010048536-A2 | PROCESSES FOR PREPARING LIPIDS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2010-04-29 | — | — | WO | claimed |
| EP-1960456-A1 | NOVEL ENERGETIC POLYPHOSPHAZENES | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2008-08-27 | — | — | EP | claimed |
| WO-2006032882-A1 | NOVEL ENERGETIC POLYPHOSPHAZENES | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2006-03-30 | — | — | WO | claimed |
| US-20260146035-A1 | FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS | DONG-A ST CO., LTD. (KR) | 2026-05-28 | — | — | US | disclosed |
| EP-4003988-B1 | 3,6-DIAMINO-PYRIDAZIN-3-YL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS PRO-APOPTOTIC AGENTS | SERVIER LAB (FR) | 2026-05-20 | — | — | EP | disclosed |
| US-20260130921-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | AcuraStem Incorporated (US) | 2026-05-14 | — | — | US | disclosed |
| US-4595690-A | Hypotensive agents | SYNTEX (U.S.A.) INC. (US) | 1986-06-17 | — | — | US | disclosed |
| US-4576905-A | Photographically useful chalcogenazoles, chalcogenazolines, and chalcogenazolinium and chalcogenazolium salts | EASTMAN KODAK COMPANY (US) | 1986-03-18 | — | — | US | disclosed |
| EP-0138362-A2 | Photographic materials containing chalcogenazoles, chalcogenazolines and chalcogenazolinium and chalcogenazolium salts | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-04-24 | — | — | EP | disclosed |
| EP-0136847-A2 | Photographically useful chalcogenazolylidene and chalcogenazolium dyes and methods for their preparation | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146035-A1 | FUSED BICYCLIC COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS | AXL, ERBB2, ERBB3 | CA2 476/4885ALDH1A1 2378/4885NPSR1 1431/4885 |
| US-20260130921-A1 | TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS | TMPRSS2, TMPRSS11D, TMPRSS6 | CA2 778/4885ALDH1A1 4774/4885NPSR1 1309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.